Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 3
2010 2
2011 3
2012 2
2013 4
2014 3
2015 5
2017 5
2018 11
2019 6
2020 6
2021 10
2022 7
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Emicizumab Prophylaxis in Hemophilia A with Inhibitors.
Oldenburg J, Mahlangu JN, Kim B, Schmitt C, Callaghan MU, Young G, Santagostino E, Kruse-Jarres R, Negrier C, Kessler C, Valente N, Asikanius E, Levy GG, Windyga J, Shima M. Oldenburg J, et al. Among authors: callaghan mu. N Engl J Med. 2017 Aug 31;377(9):809-818. doi: 10.1056/NEJMoa1703068. Epub 2017 Jul 10. N Engl J Med. 2017. PMID: 28691557 Free article. Clinical Trial.
Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies.
Callaghan MU, Negrier C, Paz-Priel I, Chang T, Chebon S, Lehle M, Mahlangu J, Young G, Kruse-Jarres R, Mancuso ME, Niggli M, Howard M, Bienz NS, Shima M, Jiménez-Yuste V, Schmitt C, Asikanius E, Levy GG, Pipe SW, Oldenburg J. Callaghan MU, et al. Blood. 2021 Apr 22;137(16):2231-2242. doi: 10.1182/blood.2020009217. Blood. 2021. PMID: 33512413 Free PMC article. Clinical Trial.
Benign Hematology.
Callaghan MU. Callaghan MU. Pediatr Clin North Am. 2018 Jun;65(3):xvii-xviii. doi: 10.1016/j.pcl.2018.03.001. Pediatr Clin North Am. 2018. PMID: 29803288 No abstract available.
Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors.
Mahlangu J, Oldenburg J, Paz-Priel I, Negrier C, Niggli M, Mancuso ME, Schmitt C, Jiménez-Yuste V, Kempton C, Dhalluin C, Callaghan MU, Bujan W, Shima M, Adamkewicz JI, Asikanius E, Levy GG, Kruse-Jarres R. Mahlangu J, et al. Among authors: callaghan mu. N Engl J Med. 2018 Aug 30;379(9):811-822. doi: 10.1056/NEJMoa1803550. N Engl J Med. 2018. PMID: 30157389 Free article. Clinical Trial.
Managing Severe Hemophilia A in Children: Pharmacotherapeutic Options.
Regling K, Callaghan MU, Sidonio R Jr. Regling K, et al. Among authors: callaghan mu. Pediatric Health Med Ther. 2022 Feb 15;13:27-35. doi: 10.2147/PHMT.S293246. eCollection 2022. Pediatric Health Med Ther. 2022. PMID: 35210899 Free PMC article. Review.
Index of suspicion.
Zadeh N, Bernstein JA, Stiasny D, Callaghan MU, Flores CE, Tytko JM, Mannarino FP, Moore J. Zadeh N, et al. Among authors: callaghan mu. Pediatr Rev. 2010 Apr;31(4):167-72. doi: 10.1542/pir.31-4-167. Pediatr Rev. 2010. PMID: 20360413 No abstract available.
Favism and Glucose-6-Phosphate Dehydrogenase Deficiency.
Zaidi AU, Callaghan MU, Ravindranath Y. Zaidi AU, et al. Among authors: callaghan mu. N Engl J Med. 2018 Mar 15;378(11):1067. doi: 10.1056/NEJMc1801271. N Engl J Med. 2018. PMID: 29542307 No abstract available.
Early stage clinical trials for the treatment of hemophilia A.
Guzzardo GM, Sidonio R Jr, Callaghan MU, Regling K. Guzzardo GM, et al. Among authors: callaghan mu. Expert Opin Investig Drugs. 2022 Nov;31(11):1169-1186. doi: 10.1080/13543784.2022.2138742. Epub 2022 Nov 9. Expert Opin Investig Drugs. 2022. PMID: 36265129 Review.
57 results